Cardiac-valve prosthesis
12 claims: 8 independent, 4 dependent
- 1A cardiac-valve prosthesis, comprising:- an armature (2) adapted for deployment in an expanded implantation position, and - a set of leaflets (3) coupled to said armature (2) for deployment therewith in said expanded position;said set of leaflets (3) being able to define, in said expanded position, a flow duct for the blood selectively obstructable by said set of prosthetic valve leaflets (30) as a result of the reversal of the direction of flow of said blood flow, wherein said armature (2) comprises: - an external portion (5), adapted for deployment to enable the anchorage of the cardiac-valve prosthesis at the implantation site;and - an internal portion (6), which supports said prosthetic valve leaflets (30) ;said external portion (5) and said internal portion (6) being substantially axially coextensive with respect to one another. characterized in that said external portion (5) of said armature (2) has a set of ribs (5) which, in said expanded position, are able to cooperate in a shape fit relationships, with the implantation site, wherein said ribs (5) in said external portion of said armature have terminal ends connected to coller parts (52).
- 2The prosthesis according to Claim 1, characterized in that said external portion (5) and said internal portion (6) of said armature (2) are structurally distinct from one another.
- 3The prosthesis according to Claim 1, characterized in that said external portion (5) and said internal portion (6) of said armature (2) form different parts of a single structure.
- 5The prosthesis according to Claim 1, characterized in that said ribs (5) have at least one portion (50) having an overall arched pattern.
- 8The prosthesis according to any one of Claims 1, 5, 6, or 7 to 8, characterized in that said ribs (5) of said external portion (5) of said armature (2) comprise, respectively, a first branch (50) and a second branch (51) that are able to extend, respectively, in a distal position and a proximal position with respect to a valve annulus site.
- 10The prosthesis according to any one of the preceding claims, characterized in that said internal portion (6) of said armature (2) comprises respective ribs (6) that are able to support said prosthetic valve leaflets (3) in a commissural position.
- 11The prosthesis according to any one of the preceding claims, characterized in that said internal portion (6) of said armature (2) comprises ribs provided with openings (61) for the passage of formations (31) for anchoring of said prosthetic valve leaflets (3).
- 12The prosthesis according to any one of the preceding claims, characterized in that said internal portion (6) of said armature (2) comprises ribs (6) grouped together into sets, said sets being in threes or multiples of three.
Independent claims12
85 paragraphs, as filed
0001The present invention relates to cardiac-valve prostheses.
0002The invention has been developed with particular attention paid to cardiac-valve prostheses that can be implanted, for example, via percutaneous route, typically via catheterism as described in the document No. <patcit id="pcit0001" dnum="US20020042651A"><text>US-A-2002/0042651</text></patcit>, or resorting to thoracic-microsurgery techniques. The preferential reference to this context of use must not, however, be interpreted as in any way limiting the scope of the invention.
0003In the course of the last few years there has begun to be considered to an ever-increasing extent the possibility of using, as an alternative to traditional cardiac-valve prostheses, whether of a mechanical type or of a biological type, valves designed to be implanted via percutaneous route (the so-called "percutaneous valves").
0004Implantation of a percutaneous valve (or implantation using thoracic-microsurgery techniques) is in fact a far less invasive act than the surgical operation required for implanting a cardiac-valve prosthesis of a traditional type.
0005Even though it is a relatively recent technology, a rather extensive and articulated literature has already been dedicated to percutaneous valves. In particular, the patent literature on the subject can be viewed as organized according to a certain number of fundamental categories.
0006A first category of the technique has concentrated on the development of a percutaneous valve prosthesis consisting substantially of a single structure comprising an anchoring element - which is able to support and fix the valve prosthesis stably in the implantation position - and prosthetic valve elements stably connected to the anchoring element - generally in the form of leaflets or flaps, which are able to regulate the blood flow according to criteria aimed at reproducing natural blood flow in the most faithful way possible.
0007The anchoring element can present a wide range of conformations, presenting, for example, the form of an annular structure consisting of one or more rings (<patcit id="pcit0002" dnum="US4056854A"><text>US-A-4 056 854</text></patcit>, <patcit id="pcit0003" dnum="US5370685A"><text>US-A-5 370 685</text></patcit>, <patcit id="pcit0004" dnum="US5545214A"><text>US-A-5 545 214</text></patcit>, <patcit id="pcit0005" dnum="US5824064A"><text>US-A-5 824 064</text></patcit> and <patcit id="pcit0006" dnum="WO0241789A"><text>WO-A-02 41 789</text></patcit>), of a so-called "safety pin" (<patcit id="pcit0007" dnum="US4994077A"><text>US-A-4 994 077</text></patcit>), of an expandable stent with an open-work or reticular tubular wall (<patcit id="pcit0008" dnum="US5411552A"><text>US-A-5 411 552</text></patcit>, <patcit id="pcit0009" dnum="EP0850607A"><text>EP-A-0 850 607</text></patcit>, <patcit id="pcit0010" dnum="DE19546692A"><text>DE-A-19 546 692</text></patcit>, <patcit id="pcit0011" dnum="US5840081A"><text>US-A-5 840 081</text></patcit>, <patcit id="pcit0012" dnum="US5855597A"><text>US-A-5 855 597</text></patcit>, <patcit id="pcit0013" dnum="US5855601A"><text>US-A-5 855 601</text></patcit>, <patcit id="pcit0014" dnum="US5957949A"><text>US-A-5 957 949</text></patcit>, <patcit id="pcit0015" dnum="WO0041652A"><text>WO-A-00 41652</text></patcit>, <patcit id="pcit0016" dnum="US6168614B1"><text>US-B1-6 168 614</text></patcit>, <patcit id="pcit0017" dnum="US20010007956A"><text>US-A-2001/0 007 956</text></patcit>, <patcit id="pcit0018" dnum="US20010010017A"><text>US-A-2001/0 010 017</text></patcit>, <patcit id="pcit0019" dnum="WO0176510A"><text>WO-A-01 76510</text></patcit>, <patcit id="pcit0020" dnum="US6454799B1"><text>US-B1-6 454 799</text></patcit>, <patcit id="pcit0021" dnum="US6482228A"><text>US-A-6 482 228</text></patcit>, <patcit id="pcit0022" dnum="WO03003943A"><text>WO-A-03 003943</text></patcit>), or again of an expandable stent consisting of a sheet or film wound in an optionally open-worked spiral (<patcit id="pcit0023" dnum="US5925063A"><text>US-A-5 925 063</text></patcit>, <patcit id="pcit0024" dnum="WO02076348A"><text>WO-A-02 076348</text></patcit>).
0008Prosthetic-valve elements usually consist of biocompatible material and generally have a structure of a membrane or leaflet type that enables connection thereof to the anchoring element according to various known techniques. There has, however, also been envisaged the use, instead of valve leaflets, of an open/close element in the form of a disk, as in <patcit id="pcit0025" dnum="US4994077A"><text>US-A-4 994 077</text></patcit>.
0009A second category of the technique has instead developed percutaneous cardiac-vaive prostheses formed by two separate structures, an anchoring element and a set of prosthetic-valve elements co-ordinating with the anchoring element. The two structures are implantable in succession one after another, with the anchoring element set in position first. An example of such a valve prosthesis with so-called "double structure" is represented by a stent in the form of a cage, with a function of support and anchoring of the valve, to which is associated a valve element in the form of an arrest ball, as described in <patcit id="pcit0026" dnum="US5332402A"><text>US-A-5 332 402</text></patcit> and <patcit id="pcit0027" dnum="US5397351A"><text>US-A-5 397 351</text></patcit>, or of an umbrella, as described in <patcit id="pcit0028" dnum="US5332402A"><text>US-A-5 332 402</text></patcit>.
0010Again, the patent literature describes elements of support and/or anchoring for valve prostheses - which can be used with valve prostheses of a different nature - having structures of the stent type, as described in <patcit id="pcit0029" dnum="DE19857887A"><text>DE-A-19 857 887</text></patcit> and <patcit id="pcit0030" dnum="WO0162189A"><text>WO-A-01 62189</text></patcit> or of an annular type, as described in <patcit id="pcit0031" dnum="US5980570A"><text>US-A-5 980 570</text></patcit>, <patcit id="pcit0032" dnum="EP1088529A"><text>EP-A-1 088 529</text></patcit> and <patcit id="pcit0033" dnum="WO0164137A"><text>WO-A-01 64137</text></patcit>.
0011Other patent documents concerning percutaneous cardiac-valve prostheses and corresponding methods of implantation are <patcit id="pcit0034" dnum="US3671979A"><text>US-A-3 671 979</text></patcit>, <patcit id="pcit0035" dnum="US4777951A"><text>US-A-4 777 951</text></patcit> and <patcit id="pcit0036" dnum="US5954766A"><text>US-A-5 954 766</text></patcit>.
0012More specifically, the invention relates to a cardiac-valve prosthesis according to the preamble of claim 1, which is known e.g. from <patcit id="pcit0037" dnum="US6425916B"><text>US-B-6 425 916</text></patcit>.
0013In general, in the fabrication of cardiac valves, and in particular in the fabrication of percutaneous cardiac valves that are to be implanted in the aortic position, it is necessary to reconcile various needs, which are in effect in contrast with one another.
0014In the first place, it is important to ensure firm anchoring of the valve in the implantation position. In particular, once implanted, the valve must not run the risk of being displaced (dislodged) with respect to the implantation position as a result of the hydraulic thrust exerted by the blood flow.
0015In the second place, it is important to ensure the tightness of the artificial duct obtained with the valve with respect to the flow duct generically defined by the natural annulus and by the root of the aorta, preventing undesirable ports for flow of the blood from possibly being set up on the outside of the structure of the valve.
0016Again, as in the case of all cardiac-valve prostheses, it is desirable to have available a structure of prosthetic valve leaflets that can reproduce as faithfully as possible the operation of natural valve leaflets, this as regards minimization of the loss of head induced on the blood flow and as regards the possibility of preventing lines of flow of the blood through the prosthesis from being set up that might depart, as regards their pattern, from the pattern of the lines of flow characteristic of natural blood flow.
0017Furthermore, it should be taken into account that the methods of implantation of valves via a percutaneous route or by means of thoracic microsurgery are very frequently irrespective of the effective removal of the natural valve leaflets. Very often it is in fact simply envisaged that the cardiac valve is in some way introduced in a position corresponding to the natural annulus and deployed <i>in situ</i> by simply divaricating definitively the natural valve leaflets, the functionality of which is destined to be replaced by the valve leaflets of the prosthetic valve.
0018The purpose of the present invention is to provide a cardiac valve capable of meeting in an excellent way the requirements indicated previously, with particular reference to the possible implantation via percutaneous route or by means of thoracic microsurgery.
0019According to the present invention, that purpose is achieved thanks to a cardiac-valve prosthesis having the characteristics referred to specifically in claim 1. Advantageous developments of the invention form the subject matter of the subclaims.
0020In a possible exemplary embodiment, the solution described herein is based on the concept of separating, in the framework of the supporting armature of the valve, the function of anchoring of the valve in the implantation site (including the possible function of sealing the valve with respect to the blood-flow duct natural to the region in which the valve is implanted) by the valve function proper. In a preferred way, that purpose is achieved by providing, within the armature of the valve, two structures (which are functionally distinct, but which in effect may be structurally integrated with one another), which are delegated separately to the accomplishment of these two functions. Envisaged herein is the fact that these two structures or portions comprise an external portion which can be spread out to enable anchorage of the cardiac-valve prosthesis in the implantation site, and an internal portion which is substantially axially coextensive with the external portion for supporting the prosthetic valve leaflets.
0021The valve thus obtained is adapted in a particularly advantageous way to be implanted in a position corresponding to the so-called Valsalva's sinuses.
0022The invention will now be described, purely by way of non-limiting example, with reference to the annexed drawings, in which: <ul id="ul0001" list-style="dash" compact="compact"><li><figref idref="f0001">Figure 1</figref> is a general perspective view of the armature of a valve according to the invention;</li><li><figref idref="f0002">Figure 2</figref> illustrates the corresponding valve without the leaflets; and</li><li><figref idref="f0003">Figures 3 and 4</figref> illustrate a second example of embodiment of a valve according to the invention.</li></ul>
0023In the figures of the annexed sheets of drawings, the reference number 1 designates as a whole a so-called cardiac valve, which can be implanted via percutaneous route or resorting to thoracic-microsurgery techniques.
0024For a circumstantiated description of the meaning attributed to these terms and of the solutions of valves already proposed in the past, the reader is referred to the introductory part of the present description.
0025The foregoing also applies as regards the general illustration of the potential advantages linked to the use of cardiac-valve prostheses of this nature and of the corresponding modalities of implantation. It is consequently superfluous herein to proceed to a new detailed exposition of these concepts, which are to be considered certainly known.
0026The same applies also to a fair extent, with the exception of the elements that will be referred to specifically in what follows, as regards the details of embodiment of a strictly technological nature (choice and treatment of the materials, etc.).
0027Essentially, the valve 1 represented in <figref idref="f0001">Figures 1</figref> and <figref idref="f0002">2</figref> is basically made up of two elements, namely: <ul id="ul0002" list-style="dash" compact="compact"><li>an armature 2, having the characteristics that emerge more clearly from the representation of <figref idref="f0002">Figure 2</figref>; and</li><li>a set of leaflets 3, coupled to the armature 2 and the characteristics of which will be illustrated in detail in what follows and may be appreciated more fully from the view of <figref idref="f0001">Figure 1</figref>.</li></ul>
0028As shown in <figref idref="f0002">Figure 2</figref>, the armature 2 of the valve has a general cage-like structure comprising a set of ribs that extend with a general symmetry of a cylindrical type about a principal axis X4.
0029In percutaneous valves, the axis X4 usually corresponds with the principal axis of the distal part of the catheter used for implantation of the valve 1.
0030For the present purposes, the axis X4 can be viewed basically as an entity of a purely geometrical nature, even though the same can in effect be identified either with elements of the implantation catheter or with elements of the armature 2 of the valve 1.
0031Basically, within the armature 2 there are distinguishable a first and a second series of ribs, designated, respectively, by the reference numbers 5 and 6.
0032These ribs are usually made of metal material that is able to present characteristics of radial expandability, both as a result of a positive action of dilatation or divarication exerted via, for example, a balloon catheter and as a result of characteristics proper to the material constituting the ribs 5 (and, possibly, 6), and in particular thanks to the possibility of it being made of a superelastic material and/or a material with shape-memory characteristics. A material that is well known in biomedical applications and that presents the characteristics just cited is the material known as Nitinol.
0033The possibility of obtaining structures that may substantially be likened to cages, which can be introduced into a vessel of the human body and in particular into a venous site and can then be dilated <i>in loco</i> via dilatation of the distal part of the catheter for introduction i.e., (in the case of materials with shape-memory characteristics or the like) as a result of the retraction of a sheath that previously maintains the structure in a compressed position, is well known in the art, having been amply experimented, for example, in stent technology, and in particular the technology of stents for angioplasty.
0034Concerning the possibility of providing cage-like structures with ribs extending with a profile more or less shaped in diametral planes with reference to a principal axis, such as for example the axis X4, further reference may be made to technologies adopted for the fabrication of devices for the mapping or passivation of endocardial sites, such as, typically, endocavitary sites, used for localization and/or treatment of the so-called ectopic sites characteristic of the pathological conditions of a fibrillative type.
0035The distinction made - at the level of reference numbers - between the ribs 5 and 6 introduced previously is aimed at taking into account the fact that, within the armature 2, these different sets of ribs are designed to perform different functions, this being true even though these ribs may constitute so many physically distinct parts as different portions of a unitary structure within the armature 2.
0036In particular, the ribs 5 form an external part or portion of the armature 2 designed (note the representation of <figref idref="f0001">Figure 1</figref>) to enable the location and anchoring of the valve 1 in the implantation site.
0037Instead, the ribs 6 are designed to constitute a more internal part of the armature 2, specifically the part that is to support - as will emerge more clearly from what follows - the valve leaflets 30 of the prosthesis.
0038Basically, the ribs 5 and 6 are designed to define, within the armature 2: <ul id="ul0003" list-style="dash" compact="compact"><li>an external portion (ribs 5), which can be spread out to enable anchorage of the prosthesis 1 in the implantation site; and</li><li>an internal portion (ribs 6), which supports the prosthetic valve leaflets 30 provided in the set of leaflets 3.</li></ul>
0039An important characteristic of the solution described herein is provided by the fact that the two parts or portions of armature previously described are "substantially axially coextensive" with respect to one another.
0040This definition is understood to indicate synthetically the fact that these two portions occupy, if observed in their development in the direction of the axis X4, axial stretches that are substantially coincident with one another.
0041The above is in direct contrast with solutions such as the one described, for example, in <patcit id="pcit0038" dnum="US6482228B"><text>US-B-6 482 228</text></patcit>: illustrated therein is a valve comprising two homologous portions that are totally staggered with respect to one another in an axial direction so that they can be located, one in a proximal position and the other in a distal position with respect to the coronary ostia.
0042The ribs 5, which in what follows are designated also as "external" ribs, are preferably arranged in sets of ribs, these sets being typically arranged in threes or multiples of three so as to be more readily adaptable - in a complementary way - to the anatomy of the Valsalva's sinuses, which is the site of choice for implantation of the valve described.
0043In the exemplary embodiment illustrated herein (which, it is recalled, is merely one example), within the ribs 5 there is distinguishable a top part or top branch 50 and a bottom part or bottom branch 51.
0044In the implantation position, the top parts or branches 50 are able, when they are in their deployed or expanded position, to extend within the so-called Valsalva's sinuses, i.e., the dilatations, from the overall lobed profile, which are present at the root of the aorta (or the pulmonary valve), hence in a physiologically distal position with respect to the valve annulus.
0045The bottom portions or branches 51 (note once again the representation of <figref idref="f0001">Figure 1</figref>) are instead designed to extend in a proximal position with respect to the valve annulus so as to extend for a certain stretch within the ventricular chamber.
0046As a whole, the top parts 50 of the ribs 5, when brought into the extended position, jointly define a tripodal structure, which, by spreading out within the Valsalva's sinuses, enables attainment of a condition of firm anchorage of the valve 1. This avoids the possibility of the valve 1, once implanted, being dislodged, or even just displaced with respect to the implantation position as a result of the hydraulic stresses applied thereto during operation by the blood flow.
0047The condition of firm anchorage of the valve 1 in the implantation site is further reinforced by the fact that the area of radiusing between the top branches 50 and the bottom branches 51 of the ribs 5 has, precisely on account of the general divaricated or flared pattern of the bottom branches 51, an area of convexity or loop that is thus positioned astride of the valve annulus, reinforcing the condition of shape fit between the armature of the valve and the implantation site.
0048It will be appreciated that, in the schematic representation of the figures, the natural valve leaflets of the valve that is to be replaced with the prosthetic valve 1 are not specifically illustrated.
0049This is intended to highlight the fact that the valve 1 described herein can be located in situ whether the natural valve leaflets have previously been removed or (and in a way that is from certain points of view preferred) without proceeding to the removal of the natural valve leaflets by simply introducing the valve within the valve orifice and thus bringing about, as a result of the divarication of the valve 1 structure, the corresponding definitive divarication of the natural valve leaflets that are brought into - and maintained in - a position of substantial adherence to the surrounding portion of the valve annulus.
0050It will moreover be appreciated that the particular conformation of the ribs 5, and in particular of the parts 50 and 51 just described, corresponds to the solution envisaged for the implantation of the valve in the aortic site. Structures that are as a whole similar can be adopted for implantations, for example, in the mitral site.
0051The top and bottom branches 50 and 51 may in actual fact present conformations that are altogether different from the ones illustrated. For example, the top branches 50 may possibly present a conformation that is approximately symmetrical to the conformation represented herein with reference to the bottom branches 51, thus conferring on the external part of the armature 2 of the valve an overall hourglass conformation. It will moreover be appreciated that the presence of both of the branches 50 and 51 is altogether optional.
0052Again, in the exemplary embodiment of the invention illustrated herein the terminal top ends of the branches 50 and the bottom ends of the branches 51 are connected to collar parts 52, which are designed to be fitted around, and usually to slide along the principal axis X4 during divarication of the armature 2. This solution proves advantageous as regards the simplicity of embodiment and the structural congruence of the armature 2. Recourse thereto should, however, be reconciled with the need to prevent the collar parts 52 from possibly ending up playing an excessive role of obstruction in regard to the blood flow that is to pass (from below upwards, with reference to the configuration of implantation as represented in <figref idref="f0001">Figure 1</figref>) through the central orifice of the valve defined between the valve leaflets 30 in a divaricated position.
0053The structure and the configuration of the ribs 6 is, as a whole, akin to that of the ribs 5.
0054In the case of the ribs 6, which form the internal part of the armature 2 of the valve, there is, however, usually the presence of just three elements that are to support in a position corresponding to homologous lines of commissure (which take on material form as sutures 31 passing through openings 61 provided on the elements 6) of the valve leaflets 30.
0055Essentially, the complex of ribs 6 and valve leaflets 30 is designed to form the normal structure of a so-called valve prosthesis of a biological type. This is a valve prosthesis which (in the form that is to be implanted with a surgical operation of a traditional type, hence of an invasive nature) has met with a wide popularity in the art.
0056The structural details of such a valve, consisting of a tubular structure made of biological material (for example, the pericardium or meningeal tissue of animal origin) subjected to treatments of passivation (with gluteraldehyde or similar compounds) or alternatively a biocompatible synthetic material, after prior possible shaping of the cusp-like areas that are to constitute the prosthetic valve leaflets 30, are amply known in the art.
0057To illustrate the detailed structure of such a valve, useful reference can be made to <patcit id="pcit0039" dnum="EP0155245B"><text>EP-B-0 155 245</text></patcit>, whilst as regards the technology of fabrication and/or treatment of the material of the prosthetic valve leaflets, useful reference can be made to <patcit id="pcit0040" dnum="EP0133420B"><text>EP-B-0 133 420</text></patcit>.
0058In addition to the more strictly "valve" part comprising the prosthetic valve leaflets 30 supported in a commissural position by the ribs 6 of the armature 2, the leaflet part of the prosthesis illustrated also has an apron-like part 32, which extends according to a general chimney-like or flared configuration, being supported by the bottom parts 51 of the external ribs 5 of the armature 2.
0059For this purpose, the bottom parts 51 have an overall V-shaped structure, hence comprising two branches that are to enclose within them the chimney-like portion 32 of the set of leaflets of the valve armature 2, so causing this to be divaricated at the moment of spreading-out of the valve and maintained in such divaricated position in the intraventricular site in a proximal position with respect to the valve annulus.
0060Albeit conserving an extreme structural simplicity, from which there derives a corresponding reliability during implantation, the valve structure described manages to meet in an excellent way various needs that in themselves contrast with one another.
0061This is obtained basically by separating the two parts of the armature (which are functionally distinct, even though they may be integrated in a single structure) and hence delegating to them two different functions.
0062In particular, the external ribs 5 (and more specifically when these are present in the two branches 50 and 51, which can set themselves astride of the valve annulus) provide the firm anchoring of the valve <i>in situ,</i> so preventing it from possibly being removed or even just displaced from the implantation site chosen by the person carrying out the implantation operation.
0063This is obtained with a structure that is able to adapt to the natural anatomical conformation without exerting thereon stresses of a traumatic nature.
0064As may be appreciated from the attached sheets of drawings, the ribs 5 can present a rather thin or light structure. This causes them possibly to adhere to the walls of the root of the aorta, to the surrounding portion of the valve annulus, and to the walls of the endocardial chamber, without exerting particularly marked stresses on those walls, which - in extreme cases - could even be at the basis of phenomena of lesions and, even more, of onset of reactions of the organism in regard to these lesions. The action of anchoring is in fact achieved, more than for any other reason, on account of the presence of numerous ribs 5 and their conformation, which is complementary with respect to that of the implantation site (in particular, when this is represented by the Valsalva's sinuses).
0065The internal part of the armature 2, represented by the ribs 6, enables, instead, spreading-out and support of the prosthetic valve leaflets 30 in the implantation position. This is achieved by recourse to a structure and a conformation which, precisely because they reproduce very closely those of traditional prosthetic valves of a biological type, prove particularly suitable and efficient for performing substitution of a defective natural valve. In particular, it is well known the fact that valve prostheses of a biological type, precisely because they are such as to reproduce much more closely the fluid-dynamic characteristics and the characteristics of behaviour of the leaflets of natural cardiac valves, can be used to benefit also in patients affected by forms of rather marked cardiac insufficiency.
0066It will be appreciated that this possibility is achieved in an optimal way in the solution described herein precisely because the valve function is rendered altogether independent of the function of anchoring in situ of the prosthesis.
0067The presence of the branches 51 in the armature 2 of the prosthesis and, conversely, of the apron-like or chimney-like portion 32 in the set of leaflets 3 (in addition to contributing further to the shape fit and hence to the anchoring in the implantation site of the valve 1) likewise enables very efficient channelling of the blood flow coming from the heart, channelling it in a practically complete way, precisely on account of the divaricated or flared configuration of the chimney-like portion 32 within the flow duct defined within the valve leaflets 30. There is thus minimized (and in effect cancelled out) in times shortly following implantation, the possibility of there being created lines of blood flow that are directed from the cardiac chamber towards the vessel that exits therefrom and are such as to pass on the outside of the cardiac-valve prosthesis.
0068The foregoing likewise envisages that the two parts or portions of armature previously described are substantially axially coextensive with respect to one another, occupying, if viewed in their development in the direction of the axis X4, axial stretches substantially coinciding with one another. This characteristic enables a precise positioning of the prosthetic valve leaflets in a "physiological" location (i.e., in a location basically corresponding to the location of the natural valve leaflets), likewise benefiting, for the purposes of the anchoring of the prosthesis in situ, from a shape fit with the Valsalva's sinuses.
0069<figref idref="f0003">Figures 3 and 4</figref> illustrate a second exemplary embodiment of a cardiac valve of the type described herein.
0070From the general structural standpoint, the valve of <figref idref="f0003">Figures 3 and 4</figref> stems basically from the structure of the valve described previously with reference to <figref idref="f0001">Figures 1</figref> and <figref idref="f0002">2</figref>.
0071The valve according to <figref idref="f0003">Figures 3 and 4</figref> is to be obtained by recourse, as regards the armature, to a single element of tubular shape and reticular structure.
0072In particular, <figref idref="f0003">Figure 3</figref> illustrates this tubular element in an "extroverted" or "extended" configuration, whereas in <figref idref="f0003">Figure 4</figref> the same element is illustrated in an "introverted" configuration, corresponding to the final conformation of implantation of the valve.
0073In this particular embodiment, the two parts or portions of the armature 2 (the external portion 5 for anchoring of the valve 1 in the implantation site and the internal portion 6 with the function of supporting the valve leaflets) are integrated in a single structure consisting precisely of the tubular element referred to previously.
0074That element, designated as a whole by 2, has a substantially cylindrical structure that develops about a principal axis X4 and consists of ribs having a general helical conformation and presenting joints in pairs 53 and 63 at the two ends. The armature 2 is without any discontinuity between the external portion 5 and the internal portion 6 of the ribs.
0075The ribs that form the element 2 in this example of embodiment are basically made of a superelastic material and/or shape-memory material.
0076The valve 1 passes from the extroverted configuration (<figref idref="f0003">Figure 3</figref>) to the introverted or final configuration (<figref idref="f0003">Figure 4</figref>) through a mechanism of deformation that may be obtained at the implantation site. This can occur, in the case of percutaneous valves, via remote manipulation devices associated to the catheter for introduction of the valve. Such devices are in themselves known in so far as they are used in association with catheters of various types, for example to obtain actions of selective spreading-out of implantation devices, such as stents, stent-grafts or the like.
0077The mechanism of deployment (i.e. "introversion") in question envisages passing from the extended conformation of <figref idref="f0003">Figure 3</figref> to the final conformation of <figref idref="f0003">Figure 4</figref>, thereby causing the joints 63 - to which the set of leaflets 3 are fixed (internally with respect to the original cylindrical tubular element) - to converge within the tubular structure and then advance therein until the joints 63 arrive in the proximity of the joints 53, which, at the start of the movement of introversion described, were exactly at the opposite end of the original cylindrical tubular element.
0078Basically, this movement causes the tubular element 2 to pass between: <ul id="ul0004" list-style="dash" compact="compact"><li>an extroverted configuration (<figref idref="f0003">Figure 3</figref>), in which the tubular element has a substantially cylindrical shape, with the external portion 5 and internal portion 6 of the armature axially juxtaposed with respect to one another, and</li><li>a final introverted configuration (<figref idref="f0003">Figure 4</figref>), in which the aforesaid external portion 5 and internal portion 6 are substantially axially coextensive with respect to one another.</li></ul>
0079This overall movement is usually accompanied by at least a slight divarication of the joints 53 and of the areas of the armature of the valve (external part 5) adjacent thereto.
0080That divarication of the joints 53 and of the areas of the armature adjacent thereto is clearly perceptible in <figref idref="f0003">Figure 4</figref>.
0081In the same figure there is moreover perceptible the action of "pinching" of the apron-like part of the leaflet, which may be achieved with a positive action of deformation of the armature and/or by exploiting the shape-memory characteristics of the constituent material.
0082It will be noted that, also in this case, a final configuration is reached, in which the external portion 5 and internal portion 6 of the armature of the valve 1 are substantially axially coextensive with respect to one another, finding themselves occupying axial stretches that substantially coincide with respect to the axis X4.
0083The introverted configuration of <figref idref="f0003">Figure 4</figref> has the ribs 5, in which it is possible to distinguish top branches 50 and bottom branches 51, in a conformation suitable for being implanted in the Valsalva's sinuses. The top branches 50 extend in a generally cage-like form, which is complementary with the lobed anatomy of the Valsalva's sinuses and co-operate with the bottom branches 51, which are to extend in a proximal position with respect to the valve annulus so as to be introduced within the ventricular chamber, ensuring a firm anchoring of the valve 1 at the implantation site.
0084The set of leaflets 3 comprises the prosthetic valve leaflets 30 supported by the internal ribs 6 and an apron-like part 32 supported by/fixed to the bottom branches 51 of the external ribs 5.
0085Of course, without prejudice to the principle of the invention, the details of construction and the forms of embodiment may vary widely with respect to what is described and illustrated herein, without thereby departing from the scope of the present invention, as defined by the annexed claims.
3 sheets
Sheet 1 Sheet 2 Sheet 3
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| US10966823B2 | Cited by | United States of America | Applicant |
| US10549101B2 | Cited by | United States of America | Applicant |
| US9918841B2 | Cited by | United States of America | Applicant |
| US12193932B2 | Cited by | United States of America | Applicant |
| US12138159B2 | Cited by | United States of America | Applicant |
| US12109111B2 | Cited by | United States of America | Applicant |
| US11464631B2 | Cited by | United States of America | Applicant |
| US11617650B2 | Cited by | United States of America | Applicant |
| US12403004B2 | Cited by | United States of America | Applicant |
| US11259922B2 | Cited by | United States of America | Applicant |
| US11389294B2 | Cited by | United States of America | Applicant |
| US10058313B2 | Cited by | United States of America | Applicant |
| US11311377B2 | Cited by | United States of America | Applicant |
| US9867695B2 | Cited by | United States of America | Applicant |
| US11357622B2 | Cited by | United States of America | Applicant |
| US12440335B2 | Cited by | United States of America | Applicant |
| US8715207B2 | Cited by | United States of America | Applicant |
| US11419720B2 | Cited by | United States of America | Applicant |
| US12201524B2 | Cited by | United States of America | Applicant |
| US12053369B2 | Cited by | United States of America | Applicant |
| US12295584B2 | Cited by | United States of America | Applicant |
| US12502276B2 | Cited by | United States of America | Applicant |
| US11793640B2 | Cited by | United States of America | Applicant |
| US11779742B2 | Cited by | United States of America | Applicant |
| US11491006B2 | Cited by | United States of America | Applicant |
| US12433743B2 | Cited by | United States of America | Applicant |
| USD1054562S | Cited by | United States of America | Applicant |
| US11311376B2 | Cited by | United States of America | Applicant |
| US10098733B2 | Cited by | United States of America | Applicant |
| US9895223B2 | Cited by | United States of America | Applicant |
| US11446140B2 | Cited by | United States of America | Applicant |
| US11737872B2 | Cited by | United States of America | Applicant |
| US11883283B2 | Cited by | United States of America | Applicant |
| US11259921B2 | Cited by | United States of America | Applicant |
| US9649495B2 | Cited by | United States of America | Applicant |
| US9931206B2 | Cited by | United States of America | Applicant |
| US10940001B2 | Cited by | United States of America | Applicant |
| US11998447B2 | Cited by | United States of America | Applicant |
| US12364587B2 | Cited by | United States of America | Applicant |
| US10856984B2 | Cited by | United States of America | Applicant |
| US12447013B2 | Cited by | United States of America | Applicant |
| US11931254B2 | Cited by | United States of America | Applicant |
| US11389291B2 | Cited by | United States of America | Applicant |
| US11602429B2 | Cited by | United States of America | Applicant |
| US11497602B2 | Cited by | United States of America | Applicant |
| US11413139B2 | Cited by | United States of America | Applicant |
| WO9724989A | Cites | World Intellectual Property Organization (WIPO) | – |
| WO03003943A | Cites | World Intellectual Property Organization (WIPO) | – |
| US2002138138A1 | Cites | United States of America | – |
| US6425916B1 | Cites | United States of America | – |
| US6482228B1 | Cites | United States of America | – |
12 members in 5 offices; this record represents the family
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| TO20040135 | Italy | – | |
| TO20040135 | Italy | A |
Members12
| Document | Office | Kind | |
|---|---|---|---|
| ITTO20040135A1 | Italy | A1 | |
| EP1570809A1 | European Patent Office (EPO) | A1 | |
| US2005197695A1 | United States of America | A1 | |
| US2008255662A1 | United States of America | A1 | |
| EP1570809B1This record | European Patent Office (EPO) | B1 | |
| AT420612T | Austria | T | |
| ATE420612T1 | Austria | T1 | |
| DE602005012331D1 | Germany | D1 | |
| US8109996B2 | United States of America | B2 | |
| US8535373B2 | United States of America | B2 | |
| US2013325112A1 | United States of America | A1 | |
| US9867695B2 | United States of America | B2 |
64 legal events, as 6 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent expired after termination of 20 yearsExpiredPE20 | PE20 | GB | |
| Expiry of rightR071 | R071 | DE | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Opt-out of the competence of the unified patent court (upc) registeredP01 | P01 | EP | |
| Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)REGISTERED BETWEEN 20221110 AND 20221116732E | 732E | GB | |
| Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)REGISTERED BETWEEN 20220210 AND 20220216732E | 732E | GB | |
| Change of applicant/patenteeR081 | R081 | DE | |
| Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)REGISTERED BETWEEN 20210318 AND 20210324732E | 732E | GB | |
| Change of applicant/patenteeR081 | R081 | DE | |
| Change of applicant/patenteeR081 | R081 | DE | |
| Change of representativeR082 | R082 | DE | |
| Fee paymentPLFP | PLFP | FR | |
| Fee paymentPLFP | PLFP | FR | |
| Fee paymentPLFP | PLFP | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents actLapsedNLV1 | NLV1 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Corresponds to:REF | REF | EP | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Title (correction)CARDIAC-VALVE PROSTHESISRTI1 | RTI1 | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Designation fees paidAKX | AKX | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1570809
- Application
- 50042894
Titles3
- German
- Herzklappenprothese
- English
- Cardiac-valve prosthesis
- French
- Prothèse de valvule cardiaque
Classification
- CPC, 4
- A61F2/2418
- A61F2/2412
- A61F2/2427
- A61F2250/0039
- IPC, 1
- A61F2 24
Designated states30
- Contracting states, 30
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Hungary
- Ireland
- Iceland
- Italy
- Liechtenstein
- Lithuania
- Luxembourg
- Monaco
- Netherlands (Kingdom of the)
- Poland
and 6 moreShow fewer
- Portugal
- Romania
- Sweden
- Slovenia
- Slovakia
- Türkiye
